X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 54 filers reported holding X4 PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57 | -41.8% | 51,968 | +2.7% | 0.00% | – |
| Q2 2023 | $98 | -90.2% | 50,600 | +37661.2% | 0.00% | – |
| Q2 2021 | $1,000 | -98.3% | 134 | -98.1% | 0.00% | – |
| Q1 2021 | $59,000 | +34.1% | 6,901 | 0.0% | 0.00% | – |
| Q4 2020 | $44,000 | -6.4% | 6,901 | 0.0% | 0.00% | – |
| Q3 2020 | $47,000 | -66.2% | 6,901 | -53.7% | 0.00% | – |
| Q2 2020 | $139,000 | +231.0% | 14,901 | +254.7% | 0.00% | – |
| Q1 2020 | $42,000 | -68.7% | 4,201 | -66.5% | 0.00% | – |
| Q4 2019 | $134,000 | +45.7% | 12,532 | +73.3% | 0.00% | – |
| Q3 2019 | $92,000 | -14.8% | 7,232 | 0.0% | 0.00% | – |
| Q2 2019 | $108,000 | +671.4% | 7,232 | +768.2% | 0.00% | – |
| Q1 2019 | $14,000 | – | 833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |